214610 — MiCo BioMed Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩75bn
- KR₩95bn
- KR₩16bn
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | — | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,585 | 4,098 | 45,672 | 30,302 | 16,111 |
Cost of Revenue | |||||
Gross Profit | -698 | -505 | 20,919 | 14,787 | -403 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 12,104 | 17,813 | 42,244 | 41,197 | 43,090 |
Operating Profit | -8,519 | -13,715 | 3,428 | -10,895 | -26,978 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -8,757 | -14,655 | -5,789 | -10,598 | -38,932 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8,757 | -14,639 | -5,776 | -10,585 | -38,919 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -8,749 | -14,632 | -5,776 | -10,575 | -38,893 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -8,749 | -14,632 | -5,776 | -10,575 | -38,893 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -536 | -511 | -253 | -372 | -1,335 |
Dividends per Share |